Exosome Diagnostics, Inc. - Product Pipeline Analysis

Date: November 28, 2012
Pages: 24
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: E7D5137D8D7EN
Leaflet:

Download PDF Leaflet

Exosome Diagnostics, Inc. - Product Pipeline Analysis
Summary

Exosome Diagnostics, Inc. (Exosome) is a pharmaceutical and healthcare company, based in the US. It develops biofluid-based molecular diagnostic tests for use in personalized medicine. The company focuses on the development and commercialization of blood-based cancer molecular diagnostics for patient stratification and disease monitoring. Its proprietary exosome technology makes use of this natural enrichment to achieve high sensitivity and specificity for rare gene transcripts and the expression of genes responsible for cancers and other diseases. The company’s minimally invasive molecular diagnostics enable to extract exosomes, which are lipid-covered microvesicles shed by solid tumors into bodily fluids, such as blood and urine of cancer patients, and detect key genes and gene mutations associated with various cancers. Exosome Diagnostics is headquartered in New York, the US.

This report is a source for data, analysis and actionable intelligence on the Exosome Diagnostics, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope
  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.
Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.
Key Facts
Exosome Diagnostics, Inc. - Major Products and Services
Exosome Diagnostics, Inc. Pipeline Products by Equipment Type
Exosome Diagnostics, Inc. Pipeline Products by Development Stage
Exosome Diagnostics, Inc. Pipeline Products by Milestone Summary
Biofluid Diagnostic Test - Cancer
Biofluid Diagnostic Test - Cancer Product Status
Biofluid Diagnostic Test - Cancer Product Description
Biofluid-Based Molecular Diagnostic Test - Brain Cancer
Biofluid-Based Molecular Diagnostic Test - Brain Cancer Product Status
Biofluid-Based Molecular Diagnostic Test - Brain Cancer Product Description
Diagnostic Assay - Prostate Cancer
Diagnostic Assay - Prostate Cancer Product Status
Diagnostic Assay - Prostate Cancer Product Description
Diagnostic Assay - Prostate Cancer Product Milestone
Exosome Diagnostics, Inc. - Key Competitors
Exosome Diagnostics, Inc. - Key Employees
Exosome Diagnostics, Inc. - Key Employee Biographies
Exosome Diagnostics, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Exosome Diagnostics, Inc., Recent Developments
Oct 26, 2012: Exosome Diagnostics Selects Promega For cGMP Clinical Sample Concentrator Kit
Mar 28, 2012: Exosome Diagnostics Names Kapil Dhingra To Board Of Directors
Feb 01, 2012: Exosome Diagnostics And LMU Receive €1.0m Grant From BMBF To Develop Blood-Based Diagnostic Tests
Oct 13, 2011: PCF And Exosome Diagnostics Collaborate To Accelerate Clinical Validation Of Exosome Biofluid Molecular Diagnostics In Prostate Cancer
Oct 04, 2011: Exosome Diagnostics Announces Senior Management Changes
May 24, 2011: Exosome Diagnostics Announces New Appointments To Scientific Advisory Board
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Exosome Diagnostics, Inc., Key Facts
Exosome Diagnostics, Inc. Key Pipeline Products by Equipment Type
Exosome Diagnostics, Inc. Key Pipeline Products by Development Stage
Exosome Diagnostics, Inc., Key Facts
Exosome Diagnostics, Inc., Major Products and Services
Exosome Diagnostics, Inc. Number of Pipeline Products by Equipment Type
Exosome Diagnostics, Inc. Pipeline Products by Equipment Type
Exosome Diagnostics, Inc. Number of Pipeline Products by Development Stage
Exosome Diagnostics, Inc. Pipeline Products by Development Stage
Exosome Diagnostics, Inc. Number of Pipeline Products By Milestone Summary
Exosome Diagnostics, Inc. Pipeline Products by Milestone Summary
Biofluid Diagnostic Test - Cancer - Product Status
Biofluid Diagnostic Test - Cancer - Product Description
Biofluid-Based Molecular Diagnostic Test - Brain Cancer - Product Status
Biofluid-Based Molecular Diagnostic Test - Brain Cancer - Product Description
Diagnostic Assay - Prostate Cancer - Product Status
Diagnostic Assay - Prostate Cancer - Product Description
Diagnostic Assay - Prostate Cancer - Product Milestone
Exosome Diagnostics, Inc., Key Employees
Exosome Diagnostics, Inc., Key Employee Biographies
Exosome Diagnostics, Inc., Other Locations
Exosome Diagnostics, Inc., Subsidiaries

LIST OF FIGURES

Exosome Diagnostics, Inc. Key Pipeline Products by Equipment Type
Exosome Diagnostics, Inc. Pipeline Products by Equipment Type
Exosome Diagnostics, Inc. Pipeline Products by Development Stage
Exosome Diagnostics, Inc. Pipeline Products by Milestone Summary

COMPANIES MENTIONED

Exosome Diagnostics, Inc.
Claros Diagnostics, Inc. - Product Pipeline Analysis US$ 750.00 Oct, 2011 · 25 pages
Focus Diagnostics, Inc. - Product Pipeline Analysis US$ 750.00 Nov, 2012 · 20 pages
Corgenix, Inc. - Product Pipeline Analysis US$ 750.00 Oct, 2011 · 17 pages
IR Diagnostyx Inc. - Product Pipeline Analysis US$ 750.00 Jun, 2012 · 20 pages
AutoGenomics, Inc. - Product Pipeline Analysis US$ 750.00 Jun, 2012 · 24 pages

Ask Your Question

Exosome Diagnostics, Inc. - Product Pipeline Analysis
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: